Tag: influenza

The Department of Health and Human Services announced Wednesday that it will fully eliminate thimerosal, a mercury-based preservative, from flu vaccines, following a formal recommendation by a federal advisory panel.

The move marks a significant shift in vaccine policy after years of mounting concern over mercury exposure, particularly in children. 

Last month, the ACIP voted to limit flu vaccines to only those free of thimerosal. The mercury-containing preservative, largely phased out of childhood vaccines by 2001, still lingers in some multi-dose flu shots. HHS Secretary Robert F. Kennedy, Jr., on Tuesday signed the advisory board’s recommendations, the department said Wednesday. –Just the News

“After more than two decades of delay, this action fulfills a long-overdue promise to protect our most vulnerable populations from unnecessary mercury exposure,” Kennedy said in a statement. “Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility. Today, we put safety first.”

Kennedy added: “With the U.S. now removing mercury from all vaccines, we urge global health authorities to follow this prudent example for the protection of children worldwide.”

Thimerosal, first introduced in the 1930s to prevent microbial contamination in multi-dose vaccine vials, was largely removed from childhood immunizations by 2001. However, it remained in some adult flu shots and doses provided through multi-use vials, which have been favored for their efficiency in mass vaccination settings.

The renewed push to remove thimerosal gained traction in the late 1990s, after the FDA Modernization Act of 1997 mandated a review of mercury in medical products. In recent decades, growing public and scientific scrutiny of cumulative mercury exposure – particularly among infants and pregnant women – has led to calls for reform.

According to HHS, 96 percent of flu vaccines for the 2024–2025 season are already thimerosal-free, meaning the transition to single-dose, preservative-free vials is unlikely to disrupt supply. Vaccine manufacturers have assured the agency that they can meet demand for both adult vaccinations and the Vaccines for Children program.

Keep reading

Dr. Reichert: “We realized we had incendiary material.”

Dr. Reichert said the researchers thought their study would prove flu vaccinations helped.

Dr. Reichert: “We were trying to do something mainstream. That’s for sure.”

Sharyl: “Were you surprised?”

Dr. Reichert: “Astonished.”

Sharyl: “Did you check the data a couple of times to make sure?”

Dr. Reichert: “Well, even more than that. We’ve looked at other countries now and the same is true.”

An important and definitive “mainstream” government study done nearly two decades ago got little attention because the science came down on the wrong side.

It found that after decades and billions of dollars spent promoting flu shots for the elderly, the mass vaccination program did not result in saving lives. In fact, the death rate among the elderly increased substantially.

The authors of the study admitted a pro-vaccine bias going into the study. Here was the history as described to me: Public health experts long assumed flu shots were effective in the elderly. But, paradoxically, all the best studies done on the question failed to demonstrate a benefit. Instead of considering that they, the experts, could be wrong–instead of believing the scientific data–the public health experts assumed the studies were wrong. After all, flu shots have to work, right?

So the NIH launched an effort to do “the” definitive study that would actually prove, for the first time, once and for all, that flu shots were beneficial to the elderly. The government would gather some of the brightest scientific minds for the research, and adjust for all kinds of factors that could be masking that presumed benefit.

Keep reading

While this Frankenstein-style injection is being marketed as a tool to stop future pandemics, the virus at the center of it all is influenza—the same virus the U.S. government has spent years manipulating through gain-of-function research and now claims is on the verge of causing the next global outbreak.

“Since 2015, most clinical work on universal vaccines has focused on the flu,” the GAO states in its May 2025 Science & Tech Spotlight report.

“Multiple universal vaccine candidates targeting the flu… have reached clinical trials.”

This aligns with what we’ve already exposed: Federal agencies have been conducting bird flu gain-of-function experiments for over a decade, pushing mRNA and DNA vaccines for poultry, and stockpiling antiviral contracts—all while whispering warnings about H5N1 jumping to humans.

The Trump administration recently announced the development of a $500 million “next-generation, universal vaccine platform” called ‘Generation Gold Standard’ that will focus on avian influenza “bird flu” jab creation.

Led by Obama-nominated Comptroller General Gene Dodaro, GAO is now confirming another next step in that orchestrated rollout: a universal flu vaccine that doesn’t just target one strain—but uses recombined fragments from many strains at once.

“Scientists can now fuse together microscopic pieces of many different virus strains, increasing the number of strains that can be targeted in a single dose,” the GAO report explains.

This isn’t a new flu shot.

It’s a molecular chimera—a biotech construct made from the stitched-together parts of viruses that don’t exist naturally.

Keep reading